Navigation Links
Children With HIV at Higher Risk of Drug Resistance
Date:4/19/2011

TUESDAY, April 19 (HealthDay News) -- About 1 in 8 children infected with HIV experiences triple-class virological failure -- meaning the virus becomes resistant to multiple drugs -- within five years of starting antiretroviral treatment, a European study shows.

That drug failure rate is higher than in adults and highlights the challenge of maintaining viral load suppression in young patients who begin antiretroviral therapy so early in life, the researchers said.

Virological failure occurs when drugs can no longer reduce the amount of HIV in a patient's blood, according to the U.S. National Institutes of Health.

The study included more than 1,000 HIV-positive children in several European countries. The children, who were infected with HIV via their mother before or at birth, were under 16 years of age and began treatment with three or more drugs between 1998 and 2008.

Along with an overall 12 percent rate of triple-class virological failure, the researchers also found that children who began antiretroviral treatment at an older age were more likely to experience failure.

One expert said that the higher rate of virological failure may be tied to lower rates of drug adherence by kids.

"HIV is a dynamic infection in which billions of virus particles are produced each day in the bodies of HIV infected persons," explained Dr. Bruce Hirsch, attending physician in Infectious Disease at North Shore University Hospital in Manhasset, N.Y. "Though each particular virus dies off in less than a day, the high rate of production and the high mutation rate requires that three active anti-viral medicines be present in the blood stream continuously for years."

"Growing up is hard to do," Hirsch added, and "taking unpalatable medications every day is hard on young kids."

But there are potential solutions.

"Easier to take combinations, better tasting syrup versions would help children cope with this infection," Hirsch said.

The study's authors agreed. "There is continued need for strategies to promote optimum drug adherence in children, caregivers and young people to minimize the likelihood of triple-class virological failure, and for development of suitable new drugs and formulations to optimize the treatment of children with treatment failure," wrote Ali Judd and colleagues at the Medical Research Council Clinical Trials Unit in London.

The study appears online April 19 in The Lancet.

More information

The New Mexico AIDS Education and Training Center has more about HIV and children.

-- Robert Preidt

SOURCES: Bruce Hirsch, M.D., attending physician, infectious disease, North Shore University Hospital, Manhasset, N.Y.; The Lancet, news release, April 19, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hope for children with rare genetic defect
2. Childrens doctors team up across state lines to fight disease
3. Study: Parents likely to embrace predictive genetic testing for their children if offered
4. Teachers-based intervention provides stress resistance in war-exposed children
5. Nationwide Childrens Hospital accepted to Neonatal Research Network
6. Minimally invasive thyroid surgery effective in children
7. Children victims of most eye injuries from aerosols
8. NCI awards $1.7 million to cancer specialist at Childrens Hospital Los Angeles
9. UT Southwestern pediatricians launch landmark childrens health study
10. How do life-threatening medical conditions in children impact quality of life?
11. Prenatal exposure to certain pollutants linked to behavioral problems in young children
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Children With HIV at Higher Risk of Drug Resistance
(Date:2/7/2016)... ... February 07, 2016 , ... ... empowers employers and organizations with the tools and information to lower the costs, ... to cut the cost of providing employee healthcare benefits by as much as ...
(Date:2/6/2016)... ... February 06, 2016 , ... US Sports Camps is proud to sponsor ... event brings together top non-profit leaders, ultimate organizations, and coaches from around the US. ... Bay Area Disc Program Director of Youth and Education, describes this year YUCC as ...
(Date:2/6/2016)... Pekin, IL (PRWEB) , ... February 06, 2016 ... ... the recovery phases of eating disorder treatment helps to reduce the frequency and ... “Tasks of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the ...
(Date:2/5/2016)... ... February 05, 2016 , ... VeloReality ... lighter, sleeker next generation LYNX VR Indoor Trainer with multi-rider capability to an ... and manufacturing not only reduce the weight of the unit, they also enhance ...
(Date:2/5/2016)... ... 2016 , ... The event is being held on April 7, 2016 from ... Triumph Over Parkinson’s will fund nearly $100,000 for research for the care and cure ... disease and is the architect of this informative event to raise awareness and funds ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at Source Capital Group,s 2016 Disruptive Growth ... at 2:15 p.m. ET on Wednesday, February 10, 2016.  ... taking place at 3:15 p.m. ET. http://www.aethlonmedical.com .  ... after the conclusion of the live event. The panel discussion ...
(Date:2/5/2016)... , February 5, 2016 ... market research report "Fetal (Labor & Delivery) and Neonatal ... Warmer, Incubator, Pulse Oximeter, Phototherapy/Jaundice Management Devices, CPAP, Capnograph, ... MarketsandMarkets, This report studies the global market over the ... estimated at USD 6.28 Billion in 2015 and is ...
(Date:2/4/2016)... Feb. 4, 2016 For hospitals considering enrollment ... already participating in the program, the Health Resources and ... as the , Mega-Guidance , could have significant impact ... published in September 2016. Essential Insights , ... Marketing , summarizes the Mega-Guidance,s key proposed changes, including ...
Breaking Medicine Technology: